Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 210-217

  Kwon, Seung Hwan ^a   Lee, Ha Kyung ^a   Kim, Ji Ah ^a   Hong, Sa Ik ^a   Kim, Hyoung Chun ^b   Jo, Tae Hyung ^c   Park, Young In ^d   Lee, Chong Kil ^e   Kim, Yong Bin ^c   Lee, Seok Yong ^a   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

^b Kangwon National University   (South Korea)

^c Univera Inc   (South Korea)

^d Korea University   (South Korea)

^e Chungbuk National University   (South Korea)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Chlorogenic acid; Learning and memory; Malondialdehyde

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; CHLOROGENIC ACID; SCOPOLAMINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLINESTERASE INHIBITION; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EX VIVO STUDY; FRONTAL CORTEX; HIPPOCAMPUS; IC 50; LATENT PERIOD; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MORIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; WORKING MEMORY; Y MAZE TEST;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; AMNESIA; ANIMALS; ANTIOXIDANTS; CHLOROGENIC ACID; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCAPE REACTION; FRONTAL LOBE; GPI-LINKED PROTEINS; HIPPOCAMPUS; LEARNING DISORDERS; MALE; MALONDIALDEHYDE; MEMORY, SHORT-TERM; MICE; MICE, INBRED ICR; MUSCARINIC ANTAGONISTS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS;

EID: 78049316797     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.001     Document Type: Article

References (44)

1. Almeida I.F., Fernandes E., Lima J.L., Valentao P., Andrade P.B., Seabra R.M., Costa P.C., Bahia M.F. Oxygen and nitrogen reactive species are effectively scavenged by Eucalyptus globulus leaf water extract. J. Med. Food 2009, 12:175-183.
2. Beatty W.W., Butters N., Janowsky D.S. Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia. Behav. Neural Biol. 1986, 45:196-211.
3. Bejar C., Wang R.H., Weinstock M. Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur. J. Pharmacol. 1999, 383:231-240.
4. Ben-Barak J., Dudai Y. Scopolamine induces an increase in muscarinic receptor level in rat hippocampus. Brain Res. 1980, 193:309-313.
5. Bernatoniene J., Masteikova R., Majiene D., Savickas A., Kevelaitis E., Bernatoniene R., Dvorackova K., Civinskiene G., Lekas R., Vitkevicius K., Peciura R. Free radical-scavenging activities of Crataegus monogyna extracts. Medicina (Kaunas) 2008, 44:706-712.
6. Bores G.M., Huger F.P., Petko W., Mutlib A.E., Camacho F., Rush D.K., Selk D.E., Wolf V., Kosley R.W., Davis L., Vargas H.M. Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. J. Pharmacol. Exp. Ther. 1996, 277:728-738.
7. Bouayed J., Rammal H., Dicko A., Younos C., Soulimani R. Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects. J. Neurol. Sci. 2007, 262:77-84.
8. Braida D., Paladini E., Griffini P., Lamperti M., Maggi A., Sala M. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Eur. J. Pharmacol. 1996, 302:13-20.
9. Cheng D.H., Tang X.C. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacol. Biochem. Behav. 1998, 60:377-386.
10. Cho E.S., Jang Y.J., Hwang M.K., Kang N.J., Lee K.W., Lee H.J. Attenuation of oxidative neuronal cell death by coffee phenolic phytochemicals. Mutat. Res. 2009, 661:18-24.
11. Chu Y.F., Brown P.H., Lyle B.J., Chen Y., Black R.M., Williams C.E., Lin Y.C., Hsu C.W., Cheng I.H. Roasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more neuroprotective than green coffees. J. Agric. Food Chem. 2009, 57:9801-9808.
12. Collerton D. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 1986, 19:1-28.
13. Dawson G.R., Bentley G., Draper F., Rycroft W., Iversen S.D., Pagella P.G. The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents. Pharmacol. Biochem. Behav. 1991, 39:865-871.
14. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
15. El-Sherbiny D.A., Khalifa A.E., Attia A.S., Eldenshary Eel D. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol. Biochem. Behav. 2003, 76:525-533.
16. Fan Y., Hu J., Li J., Yang Z., Xin X., Wang J., Ding J., Geng M. Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci. Lett. 2005, 374:222-226.
17. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci. 1991, 14:220-223.
18. Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 1999, 66:137-147.
19. Giacobini E. The cholinergic system in Alzheimer disease. Prog. Brain Res. 1990, 84:321-332.
20. Hebbel R.P., Shalev O., Foker W., Rank B.H. Inhibition of erythrocyte Ca2+-ATPase by activated oxygen through thiol- and lipid-dependent mechanisms. Biochim. Biophys. Acta 1986, 862:8-16.
21. Ito H., Sun X.L., Watanabe M., Okamoto M., Hatano T. Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Biosci. Biotechnol. Biochem. 2008, 72:885-888.
22. Jeong E.J., Lee K.Y., Kim S.H., Sung S.H., Kim Y.C. Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. Eur. J. Pharmacol. 2008, 588:78-84.
23. Joseph J.A., Strain J.G., Jimenez N.D., Fisher D. Oxidant injury in PC12 cells-a possible model of calcium "dysregulation" in aging: I. Selectivity of protection against oxidative stress. J. Neurochem. 1997, 69:1252-1258.
24. Kim S.S., Park R.Y., Jeon H.J., Kwon Y.S., Chun W. Neuroprotective effects of 3, 5-dicaffeoylquinic acid on hydrogen peroxide-induced cell death in SH-SY5Y cells. Phytother. Res. 2005, 19:243-245.
25. Kopelman M.D., Corn T.H. Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome. Brain 1988, 111(Pt 5):1079-1110.
26. Kwon S.H., Kim H.C., Lee S.Y., Jang C.G. Loganin improves learning and memory impairments induced by scopolamine in mice. Eur. J. Pharmacol. 2009, 619:44-49.
27. Lapchak P.A. The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: synergism with tissue plasminogen activator. Exp. Neurol. 2007, 205:407-413.
28. LeDoux J.E. Emotional memory systems in the brain. Behav. Brain Res. 1993, 58:69-79.
29. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995, 45:1594-1601.
30. Maas M., Petereit F., Hensel A. Caffeic acid derivatives from Eupatorium perfoliatum L. Molecules 2009, 14:36-45.
31. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A., Freedman M.L. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 1998, 150:40-44.
32. McIntyre K.L., Harris C.S., Saleem A., Beaulieu L.P., Ta C.A., Haddad P.S., Arnason J.T. Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium). Planta Med. 2009, 75:286-292.
33. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
34. Nakajima Y., Shimazawa M., Mishima S., Hara H. Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sci. 2007, 80:370-377.
35. Namba T., Matsuse T. A historical study of coffee in Japanese and Asian countries: focusing the medicinal uses in Asian traditional medicines. Yakushigaku Zasshi 2002, 37:65-75.
36. Palmer A.M. The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J. Neural Transm. 1999, 106:317-328.
37. Ren Y., Houghton P.J., Hider R.C., Howes M.J. Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza. Planta Med. 2004, 70:201-204.
38. Sakurai T., Kato T., Mori K., Takano E., Watabe S., Nabeshima T. Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: an in vivo microdialysis study. Neurosci. Lett. 1998, 246:69-72.
39. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berl) 1988, 94:491-495.
40. Schroeter H., Williams R.J., Matin R., Iversen L., Rice-Evans C.A. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radic. Biol. Med. 2000, 29:1222-1233.
41. Silva B.A., Dias A.C., Ferreres F., Malva J.O., Oliveira C.R. Neuroprotective effect of H. perforatum extracts on beta-amyloid-induced neurotoxicity. Neurotox. Res. 2004, 6:119-130.
42. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr. Opin. Lipidol. 1994, 5:422-433.
43. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982, 215:1237-1239.
44. Yu S.P., Canzoniero L.M., Choi D.W. Ion homeostasis and apoptosis. Curr. Opin. Cell Biol. 2001, 13:405-411.